Pregabalin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69097-956
  • Package NDC 69097-956-05
  • Package NDC 69097-956-12
  • Application number ANDA211384
  • SPL ID 96d9d734-42e6-474d-a75e-0381de0a8ec1
  • SPL set ID 17a8087c-579f-42de-ae92-006ea64def2a
  • UNII 55JG375S6M
  • RxCUI 483438
  • RxCUI 483440
  • RxCUI 483442
  • RxCUI 483444
  • RxCUI 483446
  • RxCUI 483448
  • RxCUI 483450
  • RxCUI 577127

What the source publishes

Labeler
Cipla USA, Inc.
Active ingredients
PREGABALIN
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69097-956_96d9d734-42e6-474d-a75e-0381de0a8ec1
{
  "name": "Pregabalin",
  "splId": "96d9d734-42e6-474d-a75e-0381de0a8ec1",
  "labels": [
    {
      "setId": "17a8087c-579f-42de-ae92-006ea64def2a",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a8087c-579f-42de-ae92-006ea64def2a",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17a8087c-579f-42de-ae92-006ea64def2a"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Cipla USA, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "90 CAPSULE in 1 BOTTLE (69097-956-05)",
      "package_ndc": "69097-956-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190719"
    },
    {
      "sample": false,
      "description": "500 CAPSULE in 1 BOTTLE (69097-956-12)",
      "package_ndc": "69097-956-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190719"
    }
  ],
  "productId": "69097-956_96d9d734-42e6-474d-a75e-0381de0a8ec1",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "69097-956",
  "deaSchedule": "CV",
  "genericName": "PREGABALIN",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "PREGABALIN",
      "strength": "75 mg/1"
    }
  ],
  "applicationNumber": "ANDA211384",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190719",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0369097955052",
      "0369097957056",
      "0369097956059",
      "0369097958053",
      "0369097954055",
      "0369097962050",
      "0369097961053"
    ],
    "unii": [
      "55JG375S6M"
    ],
    "rxcui": [
      "483438",
      "483440",
      "483442",
      "483444",
      "483446",
      "483448",
      "483450",
      "577127"
    ],
    "spl_set_id": [
      "17a8087c-579f-42de-ae92-006ea64def2a"
    ],
    "manufacturer_name": [
      "Cipla USA, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69097-956_96d9d734-42e6-474d-a75e-0381de0a8ec1"